In susceptible brain regions of AD patients, such as the frontal lobe and hippocampus, there is a significant increase in astrocytes expressing A1-type markers such as complement C3, compared to normal controls, suggesting A1-type astrocyte activation. The gene discussed is C3; the disease is Alzheimer disease.